Safety, tolerability and impact on viral reservoirs of the addition to antiretroviral therapy of ABX464, an investigational antiviral drug, in individuals living with HIV-1: a Phase IIa randomised controlled study.

Safety, tolerability and impact on viral reservoirs of the addition to antiretroviral therapy of ABX464, an investigational antiviral drug, in individuals living with HIV-1: a Phase IIa randomised controlled study. — المؤلف: Rutsaert, Sofie — Journal of virus eradication Jan 2019

المؤلف
Rutsaert, Sofie
النشر
Journal of virus eradication Jan 2019
الوصف
10-22 p.